IFEC   20925
INSTITUTO DE FARMACOLOGIA EXPERIMENTAL DE CORDOBA
Unidad Ejecutora - UE
congresos y reuniones científicas
Título:
Molecular mechanisms underlying promotor effect of IGF-1 on the formation of a fear memory trace
Autor/es:
ESPEJO P.; CALFA G.; HERRERA MACARENA; COMAS MUTI R.; HEREÑÚ C.; CHAMPARINI LEANDRO; OTAMENDI ANDREA; MOLINA V.
Reunión:
Congreso; SAN 2019; 2019
Resumen:
Molecular mechanisms underlying promotor effect of IGF-1 on the formation of a fear memory traceBasolateral amygdala complex (BLA) plays an essential role in the generation of an emotional state caused by an aversive experience. Insulin like growth factor I (IGF-I) could modulate hippocampal circuits modifying cognitive functions, and possibly, the molecular mechanisms involved in some psychopathologies related to traumatic memories.Objective To evaluate the formation of a memory trace through BLA IGF-I gene therapy and synaptic and molecular changes in dorsal hippocampus (HD) and BLA associated with the formation of this memory trace.M&M: Adult male Wistar rats were bilaterally infused into BLA with RAd-IGF-I, and RAd-Ds-Red as control. 7 days later we performed a weak fear conditioning protocol (WFCP). Freezing behavior (FB) was assessed at 7th and 14th day. HD synaptic plasticity was assesed through dendritic spine analysis. BLA and HD were obtained for protein analysis.Results: A significantly increase in FB in the RAd-IGF-1 group was observed after 7 days and 14 days post injection. There was a significant increase in mature spines after RAd-IGF-1 treatment. pERK/ERKt level was increased in BLA in RAd-IGF-1 group at the time WFCP was performed.Conclusions: IGF-I gene therapy induces a significant expression of FB in a WFCP, with a possible promotor effect on the formation of a fear memory trace. This behavioral expression was coincident with changes in HD dendritic plasticity. This effect could be partially attributed to MAPK/ERK pathway activation in BLA